litlas
ログインアカウント作成

Miloslav Beran

1982–2011 年に発表

76
論文数
18,397
被引用数
75
h 指数
76
i10 指数

被引用数

Miloslav Beran の年別被引用数1983 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 2 件1987 年: 被引用 8 件1988 年: 被引用 3 件1989 年: 被引用 7 件1990 年: 被引用 6 件1991 年: 被引用 24 件1992 年: 被引用 26 件1993 年: 被引用 12 件1994 年: 被引用 24 件1995 年: 被引用 47 件1996 年: 被引用 47 件1997 年: 被引用 40 件1998 年: 被引用 58 件1999 年: 被引用 78 件2000 年: 被引用 104 件2001 年: 被引用 115 件2002 年: 被引用 218 件2003 年: 被引用 210 件2004 年: 被引用 138 件2005 年: 被引用 179 件2006 年: 被引用 227 件2007 年: 被引用 198 件2008 年: 被引用 165 件2009 年: 被引用 155 件2010 年: 被引用 157 件2011 年: 被引用 147 件2012 年: 被引用 161 件2013 年: 被引用 161 件2014 年: 被引用 144 件2015 年: 被引用 133 件2016 年: 被引用 133 件2017 年: 被引用 106 件2018 年: 被引用 105 件2019 年: 被引用 275 件2020 年: 被引用 289 件2021 年: 被引用 225 件2022 年: 被引用 159 件2023 年: 被引用 93 件2024 年: 被引用 148 件2025 年: 被引用 48 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,224 件、この内訳の 37.4%ドイツ: 引用元論文 462 件、この内訳の 7.8%イギリス: 引用元論文 420 件、この内訳の 7%イタリア: 引用元論文 322 件、この内訳の 5.4%フランス: 引用元論文 308 件、この内訳の 5.2%中国: 引用元論文 290 件、この内訳の 4.9%日本: 引用元論文 179 件、この内訳の 3%カナダ: 引用元論文 164 件、この内訳の 2.7%スペイン: 引用元論文 160 件、この内訳の 2.7%オランダ: 引用元論文 138 件、この内訳の 2.3%スイス: 引用元論文 131 件、この内訳の 2.2%オーストラリア: 引用元論文 106 件、この内訳の 1.8%
0%37.4%その他 17.6%

機関

分野

  • Medicine75.1%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Immunology and Microbiology3%
  • Chemistry0.3%
  • Computer Science0.3%
  • Nursing0.2%
  • その他0.6%

トピック

  • Acute Myeloid Leukemia Research14.3%
  • Chronic Myeloid Leukemia Treatments7.8%
  • Chronic Lymphocytic Leukemia Research6.5%
  • Acute Lymphoblastic Leukemia research6.1%
  • Epigenetics and DNA Methylation4.6%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.4%
  • その他56.3%

共著者

全論文

検索で開く
  1. Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation

    著者: Kelly Moran-Crusio, Linsey B. Reavie, Alan H. Shih, Omar Abdel‐Wahab, Delphine Ndiaye‐Lobry, Camille Lobry, María E. Figueroa, Aparna Vasanthakumar, Jay Patel, Xinyang Zhao, Fabiana Perna, Suveg Pandey, Jozef Madžo, Chun‐Xiao Song, Qing Dai, Chuan He, Sherif Ibrahim, Miloslav Beran, Jiří Zavadil, Stephen D. Nimer, Ari Melnick, Lucy A. Godley, Iannis Aifantis, Ross L. Levine - Cancer Cell 2011 被引用: 1,311

  2. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    著者: Hagop M. Kantarjian, Susan O’Brien, Terry L. Smith, Jörge E. Cortes, Francis J. Giles, Miloslav Beran, Sherry Pierce, Yang O. Huh, Michael Andreeff, Charles Koller, Chul S. Ha, Michael J. Keating, Sharon Murphy, Emil J. Freireich - Journal of Clinical Oncology 2000 被引用: 795

  3. Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia

    著者: Hagop M. Kantarjian, Deborah A. Thomas, Susan O’Brien, Jörge E. Cortes, Francis J. Giles, Sima Jeha, Carlos E. Bueso‐Ramos, Sherry Pierce, Jianqin Shan, Charles Koller, Miloslav Beran, Michael J. Keating, Emil J. Freireich - Cancer 2004 被引用: 632

  4. Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse

    著者: Farhad Ravandi, Hagop M. Kantarjian, Stefan Faderl, Guillermo Garcia‐Manero, Susan O’Brien, Charles Koller, Sherry Pierce, Mark Brandt, Deborah D. Kennedy, Jörge E. Cortes, Miloslav Beran - Leukemia Research 2009 被引用: 124

  5. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

    著者: Omar Abdel‐Wahab, Ann Mullally, Cyrus V. Hedvat, Guillermo Garcia‐Manero, Jay Patel, Martha Wadleigh, Sébastien Malinge, JinJuan Yao, Outi Kilpivaara, Rukhmi Bhat, Kety Huberman, Sabrena Thomas, Igor Dolgalev, Adriana Heguy, Elisabeth Paietta, Michelle M. Le Beau, Miloslav Beran, Martin S. Tallman, Benjamin L. Ebert, Hagop M. Kantarjian, Richard M. Stone, D. Gary Gilliland, John D. Crispino, Ross L. Levine - Blood 2009 被引用: 718

  6. FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic Leukemia

    著者: Benjamin H. Lee, Zuzana Tóthová, Ross L. Levine, Kristina Anderson, Natalija Buza-Vidas, Dana E. Cullen, Elizabeth McDowell, Jennifer Adelsperger, Stefan Fröhling, Brian J.P. Huntly, Miloslav Beran, Sten Eirik W. Jacobsen, D. Gary Gilliland - Cancer Cell 2007 被引用: 225

  7. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma

    著者: Deborah A. Thomas, Susan O’Brien, Jörge E. Cortes, Francis J. Giles, Stefan Faderl, Srđan Verstovšek, Alessandra Ferrajoli, Charles Koller, Miloslav Beran, Sherry Pierce, Chul S. Ha, Fernando Cabanillas, Michael J. Keating, Hagop M. Kantarjian - Blood 2004 被引用: 251

  8. Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study

    著者: Steven M. Kornblau, Deborah E. Banker, Derek L. Stirewalt, Danny D. Shen, Elizabeth Lemker, Srđan Verstovšek, Zeev Estrov, Stefan Faderl, Jörge E. Cortes, Miloslav Beran, C. Ellen Jackson, Wenjing Chen, Elihu H. Estey, Frederick R. Appelbaum - Blood 2006 被引用: 136

  9. Report of an international working group to standardize response criteria for myelodysplastic syndromes.

    著者: Bruce D. Cheson, John M. Bennett, Hagop M. Kantarjian, António E. Pinto, Charles A. Schiffer, Stephen D. Nimer, Bob Löwenberg, Miloslav Beran, Theo M. de Witte, Richard M. Stone, Moshe Mittelman, Guillermo Sanz, P. Wijermans, Steven D. Gore, Peter L. Greenberg - 2000 被引用: 665

  10. Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

    著者: B. Douglas Smith, Mark J. Levis, Miloslav Beran, Francis J. Giles, Hagop M. Kantarjian, Karin D. Berg, Kathleen M. Murphy, Tianna Dauses, Jeffrey Allebach, Donald Small - Blood 2004 被引用: 629

  11. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

    著者: Francesco Onida, Hagop M. Kantarjian, Terry L. Smith, Greg Ball, Michael J. Keating, Elihu H. Estey, Armand B. Glassman, Maher Albitar, Monica Kwari, Miloslav Beran - Blood 2002 被引用: 386

  12. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia

    著者: William G. Wierda, Susan O’Brien, Xuemei Wang, Stefan Faderl, Alessandra Ferrajoli, Kim‐Anh Do, Jörge E. Cortes, Deborah A. Thomas, Guillermo Garcia‐Manero, Charles Koller, Miloslav Beran, Francis J. Giles, Farhad Ravandi, Susan Lerner, Hagop M. Kantarjian, Michael J. Keating - Blood 2007 被引用: 350

  13. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

    著者: Elihu H. Estey, Peter F. Thall, Michael Andreeff, Miloslav Beran, Hagop M. Kantarjian, Susan O’Brien, SM Escudier, L. E. Robertson, Charles Koller, Steven M. Kornblau - Journal of Clinical Oncology 1994 被引用: 297

  14. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

    著者: Razelle Kurzrock, Mordechai Shtalrid, Paolo Romero, William S. Kloetzer, Moshe Talpas, José M. Trujillo, Mark Blick, Miloslav Beran, Jordan U. Gutterman - Nature 1987 被引用: 274

  15. Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

    著者: Elihu H. Estey, Peter F. Thall, Miloslav Beran, Hagop M. Kantarjian, Sherry Pierce, Michael J. Keating - Blood 1997 被引用: 236

  16. Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib

    著者: Patricia Ault, Hagop M. Kantarjian, Susan O’Brien, Stefan Faderl, Miloslav Beran, Mary Beth Rios, Charles Koller, Francis J. Giles, Michael J. Keating, Moshe Talpaz, Jörge E. Cortes - Journal of Clinical Oncology 2006 被引用: 232

  17. FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

    著者: Rui Zheng, Mark J. Levis, Obdulio Piloto, Patrick A. Brown, Brenda R. Baldwin, Norbert Claude Gorin, Miloslav Beran, Zhenping Zhu, Dale L. Ludwig, Dan Hicklin, Larry Witte, Yiwen Li, Donald Small - Blood 2003 被引用: 203

  18. AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia

    著者: Mirna Golemović, Srđan Verstovšek, Francis J. Giles, Jörge E. Cortes, Taghi Manshouri, Paul W. Manley, Jürgen Mestan, Margaret Dugan, Leila Alland, James D. Griffin, Ralph B. Arlinghaus, Tong Sun, Hagop M. Kantarjian, Miloslav Beran - Clinical Cancer Research 2005 被引用: 202

  19. Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase

    著者: Susan O’Brien, Hagop M. Kantarjian, M Keating, Miloslav Beran, Charles Koller, L. E. Robertson, J Hester, MB Rios, M. Andreeff, Moshe Talpaz - Blood 1995 被引用: 182

  20. Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemia

    著者: Elihu H. Estey, Francis J. Giles, Miloslav Beran, Susan O’Brien, Sherry Pierce, Stefan Faderl, Jörge E. Cortes, Hagop M. Kantarjian - Blood 2002 被引用: 176

  21. PEG‐IFN‐α‐2b therapy in BCR‐ABL–negative myeloproliferative disorders

    著者: Elias Jabbour, Hagop M. Kantarjian, Jörge E. Cortes, Deborah A. Thomas, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Stefan Faderl, Mary Ann Richie, Miloslav Beran, Francis J. Giles, Srđan Verstovšek - Cancer 2007 被引用: 113

  22. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia

    著者: Francesco Onida, Greg Ball, Hagop M. Kantarjian, Terry L. Smith, Armand B. Glassman, Maher Albitar, Barbara Scappini, Mary Beth Rios, Michael J. Keating, Miloslav Beran - Cancer 2002 被引用: 101

  23. Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

    著者: Omar Abdel‐Wahab, Animesh Pardanani, Jay Patel, Martha Wadleigh, Terra L. Lasho, Adriana Heguy, Miloslav Beran, D. Gary Gilliland, Ross L. Levine, Ayalew Tefferi - Leukemia 2011 被引用: 229

  24. RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant

    著者: Clara Ricci, Elisa Fermo, Stefania Corti, Mauro Molteni, Alessio Faricciotti, Agostino Cortelezzi, Giorgio La Nasa, Miloslav Beran, Francesco Onida - Clinical Cancer Research 2010 被引用: 137